Celecoxib and Diclofenac Plus Omeprazole are Similarly Effective in the Treatment of Arthritis in Patients at High GI Risk in the CONDOR Trial.
CONCLUSIONS: Celecoxib and diclofenac plus omeprazole were shown to have similar efficacy in patients with OA and/or RA at increased GI risk who were enrolled in the CONDOR trial.
TRIAL REGISTRY: Trial was registered under ClinicalTrials.gov identifier NCT00141102.
PMID: 24358067 [PubMed]
Source: Open Rheumatology Journal - Category: Rheumatology Tags: Open Rheumatol J Source Type: research
More News: Arthritis | Celebrex | Diclofenac | Gastroenterology | Helicobacter Pylori | Omeprazole | Osteoarthritis | Prilosec | Rheumatoid Arthritis | Rheumatology | Study | Voltaren